Lotus Pharmaceutical Co., Ltd. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Lotus Pharmaceutical Co., Ltd.

Patent Number:
Title:
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof
Opposition Date:
Apr 29, 2022

Competitors of Lotus Pharmaceutical Co., Ltd.

CELGENE CORPORATION

Want to track Lotus Pharmaceutical Co., Ltd.?

Feel free to send us a message here and we will get back to you